Genotypes

Prevalence (%)

Overall population (N = 156)

n (%)

Cancer population (N = 61)

n (%)

Control population (N = 95)

n (%)

HPV

38 (24.4)

12 (19.67)

26 (27.36) (p = 0.367)

HPV

high risks

(HR-HPV)

HR-HPV

6 (3.85)

0

6 (6.32)

HPV18

2 (1.28)

0

2 (2.11)

HPV26

3 (1.92)

0

3 (3.16)

HPV69

1 (0.64)

0

1 (1.05)

HPV

Low risks

(LR-HPV)

LR-HPV

26 (16.67)

9 (14.75)

17 (17.89)

HPV6

23 (14.74)

9 (14.75)

14 (14.74)

HPV42

1 (0.64)

0

1 (1.05)

HPV43

1 (0.64)

0

1 (1.05)

HPV70

1 (0.64)

0

1 (1.05)

Co-infection

Co-infection

6 (3.85)

3 (9.84)

3 (3.16)

HPV6+18

1 (0.64)

1 (0.02)

0

HPV6+56

2 (1.28)

2 (0.33)

0

HPV6+HPV69

1 (0.64)

0

1 (1.05)

HPV56+44

1 (0.64)

0

1 (1.05)

HPV58+18

1 (0.64)

0

1 (1.05)